We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Magnetic Bead Fluorescent Immunoassay Detects Novel Inflammation Marker

By LabMedica International staff writers
Posted on 12 Jan 2016
Print article
The ESE Quant Tube Scanner
The ESE Quant Tube Scanner (Photo courtesy of QIAGEN)
A magnetic bead fluorescent sandwich immunoassay has been developed that allows rapid serum measurement of the novel inflammation marker at the point of care (POC) that could aid pneumonia diagnosis.

Pneumonia is an acute infection caused by various bacteria and virus species and the disease is characterized by augmented bronchoalveolar liquid and pus congesting the respiratory tract, resulting in shortness of breath.

Scientists at the Technische Universität München (Munich, Germany) obtained healthy blood donor sera, and patient sera were collected from those with radiologically confirmed pneumonia. A rapid and simple magnetic bead-based immunoassay was developed for the detection of the novel biomarker chitinase-3-like protein 1 (CHI3L1), and also known as YKL40, in an innovative POC-ready device for assistance in the diagnosis of pneumonia.

The study was performed using the ESE Quant Tube Scanner device (QIAGEN Lake Constance GmbH; Stockach Germany). Excitation and emission wavelengths were adjusted to 625 and 680 nm, respectively, to fit the spectral properties of the fluorescent 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one (DDAO). The ESE Quant Tube Scanner uses a confocal microfluorescence reader, which is small enough to be automatically positioned under each tube. The measurement is repeated every 20 seconds, leading to the recording of the time course of substrate turnover.

The assay procedure, from sample addition to data retrieval, consists of three steps and is performed in less than 20 minutes. The assay has a linear range from 3 ng/mL to 111 ng/mL, with a limit of detection of 2.9 ng/mL. The average recoveries were found between 101 and 111%. The mean calculated serum concentration of patients with pneumonia was 334 ng/mL ± 225 ng/mL (median 300 ng/mL, range 107–821 ng/mL), while serum samples from healthy donors averaged at 50 ng/mL ± 49 ng/mL (median 35 ng/mL, range 9–199 ng/mL).

The authors concluded that the magnetic bead fluorescence immunoassay is a proof of concept that can accurately and rapidly receive protein biomarker data using antibodies bound to magnetic beads in a POC-ready device, providing a simple alternative immunoassay that could help optimize pneumonia diagnosis in low resource settings. The key features of the presented assay are a rapid fluorescence measurement below 20 minutes, a detection limit that corresponds well to the lower reference range of this inflammation serum marker, and usage of an inexpensive and robust device. The study was published in the December 2015 issue of the Journal of Immunological Methods.

Related Links:

Technische Universität München 
QIAGEN Lake Constance GmbH 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The research team has developed the uCR-Chip device to enhance kidney function testing (Photo courtesy of University of Manitoba)

Low-Cost Portable Screening Test to Transform Kidney Disease Detection

Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.